Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 14

Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy

Total article views   Abstract views HTML views PDF downloads Totals
1,515 Dovepress* 918 568+ 303 1,486
PubMed Central* 0 29 15 29
Totals 918 597 318 1,515
*Since 18 January 2021
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar